Novaken Pharm's last reported valuation, Nov 2025. Nothing priced has surfaced since.
- ·Watch Novaken Pharm: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Novaken Pharm funding history
No funding rounds for Novaken Pharm are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Novaken Pharm valuation
Novaken Pharm's last reported valuation was $215 million in Nov 2025. No priced round, secondary trade or fund mark has surfaced since.
How Novaken Pharm's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Novaken Pharm, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →
Frequently asked about Novaken Pharm
- What is Novaken Pharm worth?
- Novaken Pharm is valued at $215.1M as of Oct 2026. Novaken Pharm's last reported valuation, Nov 2025. Nothing priced has surfaced since.
- How much has Novaken Pharm raised?
- Novaken Pharm has raised $39.1M in total funding across its recorded rounds.